Drug Development, Treatments on the Horizon and Stem Cells
March 2, 2017
During this session, the panel provides an overview of how drugs are developed and how newer drugs may impact drug selection, as well as various active and recently completed clinical trials.
Kelly Chin, MD, UT Southwestern
Patricia George, MD,, UPMC
Vallerie McLaughlin, MD, University of Michigan